Top Markets
Coin of the day
Neoleukin Therapeutics, Inc. Neoleukin Therapeutics, Inc.

Neoleukin Therapeutics, Inc.

NLTX
Classement en actions #26679
Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused... Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused on developing immune-based treatments for conditions such as cancer, inflammatory responses, and autoimmune diseases, utilizing its proprietary protein design technology. The company's leading investigational therapy is NL-201, a novel protein meticulously crafted to emulate the therapeutic effects of the IL-2/IL-15 cytokines. This product candidate is intended for the management of various malignancies, including renal cell carcinoma and melanoma. The organization, founded in 2003, was previously known as Aquinox Pharmaceuticals, Inc. before officially changing its name to Neoleukin Therapeutics, Inc. in August 2019. Its operations are based out of Seattle, Washington.
Prix de l'action
$3.49
Dernière synchronisation: 2023-12-19
Capitalisation boursière
$38.68M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Neoleukin Therapeutics, Inc. (NLTX)

Catégorie

Historique des divisions d’actions pour Neoleukin Therapeutics, Inc. (NLTX)
L’action Neoleukin Therapeutics, Inc. (symbole : NLTX) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 20, 2026.
Une action NLTX achetée avant le Aug 20, 2026 équivaudrait aujourd’hui à 0 actions NLTX.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes